However treatment with DYN decreased A-MLV-Env-HIV-1 infection and VSV-G-HIV-1 infection by 75±5% and 89±1% respectively, showing that the affect on HIV-1 Env-mediated infection was not as significant (Figure S11). Here, ERVW-1 is linked to infection.